Testosterone Gel in Poor Responders Undergoing IVF

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The main purpose of this study is to compare the number of oocytes retrieved after using transdermal testosterone gel 10 mg per day or Dehydroepiandrosterone (DHEA) 75mg per day for 6-8 weeks as pre-treatment for poor ovarian responders undergoing in-vitro fertilization (IVF).
Epistemonikos ID: a3b57ba5c65ad5a845d1b05d728f9b22421c59c5
First added on: May 12, 2024